Becton Dickinson Warns of Blood Culture Product Delays
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
Jim Lebenthal of Cerity Partners hyped UnitedHealth Group Incorporated (NYSE:UNH) as a "solid" healthcare company in the latest edition of CNBC's "Halftime Report Final Trades." On July 9, Cantor
Wells Fargo Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $290
Wells Fargo analyst Larry Biegelsen maintains $Becton Dickinson & Co(BDX.US)$ with a buy rating, and maintains the target price at $290.According to TipRanks data, the analyst has a success rate of 58
Express News | Citigroup Maintains Neutral on Becton Dickinson, Lowers Price Target to $255
Becton Dickinson's Stock Bounces as FDA Addresses Supply Issue With Blood-culture Vials
By Tomi Kilgore Medical-supply company looks to fill gaps as former supplier restarts production of vials Shares of Becton Dickinson & Co. bounced back Wednesday toward their first gain in seven
Express News | BD Committed To Global Health; Mitigating Blood Culture Vial Supplier Issue With FDA Collaboration, Rapid Production, And Restarting Glass Vial Production; Manual Allocation To Prioritize Clinical Needs; No Material Financial Impact Expected
Express News | Bd - Bd Bactec Blood Culture Vials Being Allocated Manually to Best Mitigate Any Impact to Patient Care
Express News | Bd: Co's Former Supplier of Glass Vials Will Restart Production to Help Fill Intermittent Gap in Supply
Express News | Bd: Experiencing Reduced Availability of Blood Culture Vials From Our Supplier
Express News | Bd - Supplier Issue Is Not Expected to Have a Material Financial Impact on Bd
Express News | Bd Statement on Supplier Issue Impacting Bd Bactec™ Blood Culture Vials
Express News | FDA: Disruption in Supply of Bd Bactec Blood Culture Media Bottles in U.S. Expected to Impact Patient Diagnosis, Follow up Patient Management
Express News | FDA Says Aware That U.S. Is Experiencing Interruptions In The Supply Of BD BACTEC Blood Culture Media Bottles Because Of Recent Supplier Issues
Express News | FDA: Aware That U.S. Is Experiencing Interruptions in the Supply of Bd Bactec Blood Culture Media Bottles Because of Recent Supplier Issues
Goldman Sachs Adjusts Price Target on Becton, Dickinson to $262 From $274
Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ.Price: 221.59, Change: +0.12, Percent Change: +0.05
Citi Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $255
Citi analyst Joanne Wuensch maintains $Becton Dickinson & Co(BDX.US)$ with a hold rating, and adjusts the target price from $260 to $255.According to TipRanks data, the analyst has a success rate of 6
Express News | Becton, Dickinson Says It Has Surpassed Its Scope 1 And 2 Science-based Greenhouse Gas (GHG) Emissions Reduction Targets For FY 2023 By 5 Percentage Points
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2...
Express News | Bd : Citigroup Cuts Target Price to $255 From $260
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now